ADA Scientific Sessions 2025 Abstract

Impact of Time of Injection Comparing iGlarLixi vs. IDegAsp in Chinese People with Type 2 Diabetes—Exploratory Analysis of the SoliD Study

Trial in peopleInterventions

The paper